TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Recludix Pharma to Present at Two Investor Conferences in November

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Matt Caldemeyer
Recludix Pharma to Present at Two Investor Conferences in November

Recludix Pharma will present at two healthcare investor conferences in November 2025, highlighting their drug discovery platform focused on developing inhibitors for inflammatory diseases, with a strategic collaboration with Sanofi and plans to submit an Investigational New Drug application for STAT6 inhibitor REX-8756.

Insights
SNY   neutral

Mentioned in a strategic collaboration with Recludix for STAT6 inhibitor development, with no additional context provided